Clinical Trials
4 results for Prostate Cancer
UTSW SBRT Prospective Clinical Registry for Oligometastic Disease, Consolidation Therapy, Debulking Prior to Chemotherapy, or Re-Irradiation
- Condition: Cancer Patients Receiving Stereotactic Body RTX
- Intervention: Radiation: SBRT
- Study ID: NCT02170181
Oligomet-DK. National Danish Protocol. Surgery+ SBRT for M1 Prostate Cancer Patients
- Condition: Prostate Cancer Metastatic
- Intervention: Procedure: RARP, Radiation: SBRT, Drug: ADT
- Study ID: NCT04086290
Fluciclovine (FACBC) PET/CT Site-Directed Therapy of Oligometastatic Prostate Cancer (Flu-BLAST-PC)
- Condition: Prostate Adenocarcinoma, PSA Level Greater Than or Equal to 0.5, PSA Level Less Than Ten
- Study ID: NCT04175431
Metastasis-directed Radiotherapy (MDRT) for Men With De-novo Oligometastatic Prostate Cancer Treated With Long-term Androgen Deprivation Therapy in the STAMPEDE Trial (METANOVA)
- Condition: Prostate Cancer, Malignant Neoplasm of Prostate, Secondary Malignant Neoplasm of Prostate
- Study ID: NCT06150417